Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Supino R et al. | 2001 | intact cell/cell culture, MCF-7 (breast cancer cell line) and normal fibroblasts | magnetic field, 50/60 Hz | 20–500 µT |
Cridland NA et al. | 1996 | intact cell/cell culture, HF-19 cells (normal human fibroblasts derived from fetal female lung) | magnetic field, 50/60 Hz, power transmission line | 20 µT–20 mT |
Mannerling AC et al. | 2010 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, low frequency, 50/60 Hz | 0.025–0.1 mT |
Kwee S et al. | 1995 | intact cell/cell culture, AMA cells (human epithelial amnion cells) and K14 cells (human skin fibroblasts) | magnetic field, low frequency, 50/60 Hz | 25–180 µT |
Wei M et al. | 2000 | intact cell/cell culture, 132-1N1 (human astrocytoma cell line) and normal rat cortical astrocytes | magnetic field, 50/60 Hz | 0.03–0.12 mT |
Paile W et al. | 1995 | intact cell/cell culture, human peripheral blood lymphocytes and human peripheral whole blood | magnetic field, signals/pulses, 50/60 Hz, occupational | 30 µT–1 mT |
Shapourzadeh A et al. | 2020 | intact cell/cell culture, adipose-derived stem cells | magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | 31.4–62.8 µT |
Kobbert C et al. | 2008 | intact cell/cell culture, bov-cSMC (bovine coronary smooth muscle cells), ms-aSMC (aortic smooth muscle cells from mice), and human endothelial cells | RF, magnetic field, low frequency, 50/60 Hz | 36 µT |
Ross SM | 1990 | intact cell/cell culture, rabbit-ligament fibroblast (RLF) cell line | magnetic field, low frequency, 50/60 Hz, DC, static magnetic field | 42–261 µT |
Mevissen M et al. | 1996 | animal, rat/Sprague-Dawley, whole body | magnetic field, 50/60 Hz, co-exposure | 50 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.